Remove Patient Care Remove Quality of Life Remove Ultrasound
article thumbnail

Results Involving Philips FDA-cleared AI-enabled Cardiovascular Ultrasound Platform to be Presented at American Society of Echocardiography Scientific Sessions, ASE 2024

DAIC

Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.

article thumbnail

Philips launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction

DAIC

Consequently, Philips is well positioned to support CVI treatment by offering a robust portfolio of medical technology that includes both intravascular ultrasound and a differentiated venous stenting system.” Ultimately, the new device promises to enable excellent clinical outcomes and drive significant quality of life improvements.”

Stents 105
article thumbnail

Cardiology Team Performs Novel Heart Artery Repair with Newly Approved Device

DAIC

We are excited to offer our patients this novel treatment that offers meaningful improvement in quality of life without the high procedural risk often associated with tricuspid surgery,” said Gagan D. Food and Drug Administration (FDA) last week. UC Davis also hosted clinical trials for the procedure in 2023. “We

Tricuspid 111
article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1) 

Cardiometabolic Health Congress

One promising strategy is the formation of creative partnerships between patients and their healthcare teams. We can revolutionize patient care and significantly reduce cardiometabolic risk by fostering collaborative relationships and leveraging diverse expertise and experiences. Here are four key strategies to achieve this: 1.Shared